Literature DB >> 1644805

Structural and immunological characterization of O-acetylated GD2. Evidence that GD2 is an acceptor for ganglioside O-acetyltransferase in human melanoma cells.

E R Sjoberg1, A E Manzi, K H Khoo, A Dell, A Varki.   

Abstract

We have shown previously that Golgi-enriched vesicles from the human melanoma cell line Melur can transfer [3H]acetate from [acetyl-3H]acetyl-CoA to endogenous GD3 to form [acetyl-3H]O-acetyl-GD3 (Manzi, A. E., Sjoberg, E. R., Diaz, S., and Varki, A. (1990) J. Biol. Chem. 265, 13091-13103). Applying the same approach in the human melanoma cell line M21, label was found in [acetyl-3H]O-acetyl-GD3 and also in a species co-migrating with unsubstituted GD3 on TLC. Both were sialidase-sensitive and alkali-labile, indicating incorporation as [3H]O-acetyl esters on sialic acids. Immunological reactivity, sialidase sensitivity, chromatographic behavior, and the known ganglioside pattern of M21 cells suggested that the slower migrating species might be [acetyl-3H]O-acetyl-GD2. Sialic acids released from this labeled molecule by sialidase showed esterification with [3H]acetate at both C7 and C9 hydroxyls. Lipid extracts from cells metabolically labeled with [3H]galactose showed a corresponding ganglioside, which upon alkali treatment yielded a species migrating with GD2. Analysis of purified ganglioside by high performance thin layer chromatography immuno-overlays, fast atom bombardment-mass spectrometry in positive and negative ion modes, periodate oxidation resistance, linkage analysis by permethylation and gas chromatography-mass spectrometry, and 500 MHz 1H NMR was consistent with the following structure: 9-O Ac-Neu5Ac alpha 2-8Neu5Ac alpha 2-3(GalNAc beta 1-4) Gal beta 1-4Gluc beta 1-1' ceramide Total gangliosides from M21 were analyzed by high performance thin layer chromatography immuno-overlay with monoclonal antibodies D1.1, JONES, 27A, and 8A2, all known to, or suspected of reacting with 9-O-acetylated gangliosides. The first three bound well to 9-O-acetyl-GD3 and a slower migrating 9-O-acetylated ganglioside, which was distinct from 9-O-acetyl-GD2. Antibody 8A2 reacted weakly with purified 9-O-acetyl-GD2 and strongly with two other 9-O-acetylated gangliosides migrating slower than 9-O-acetyl-GD2. Thus, the family of O-acetylated gangliosides in melanoma cells is much more complex than previously appreciated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644805

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Perspectives on the significance of altered glycosylation of glycoproteins in cancer.

Authors:  Y J Kim; A Varki
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

2.  Combined sialic acid and histone deacetylase (HDAC) inhibitor treatment up-regulates the neuroblastoma antigen GD2.

Authors:  Renske J E van den Bijgaart; Michiel Kroesen; Melissa Wassink; Ingrid C Brok; Esther D Kers-Rebel; Louis Boon; Torben Heise; Monique van Scherpenzeel; Dirk J Lefeber; Thomas J Boltje; Martijn H den Brok; Peter M Hoogerbrugge; Christian Büll; Gosse J Adema
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

3.  Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside.

Authors:  S Faraj; M Bahri; S Fougeray; A El Roz; J Fleurence; J Véziers; M D Leclair; E Thébaud; F Paris; S Birklé
Journal:  Oncoimmunology       Date:  2017-09-21       Impact factor: 8.110

4.  Identification of 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac2) as main O-acetylated sialic acid species of GD2 in breast cancer cells.

Authors:  Sumeyye Cavdarli; Justine H Dewald; Nao Yamakawa; Yann Guérardel; Mickaël Terme; Jean-Marc Le Doussal; Philippe Delannoy; Sophie Groux-Degroote
Journal:  Glycoconj J       Date:  2019-01-05       Impact factor: 2.916

Review 5.  Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin.

Authors:  Guido Kohla; Eggert Stockfleth; Roland Schauer
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

6.  Metabolism of vertebrate amino sugars with N-glycolyl groups: incorporation of N-glycolylhexosamines into mammalian glycans by feeding N-glycolylgalactosamine.

Authors:  Anne K Bergfeld; Oliver M T Pearce; Sandra L Diaz; Roger Lawrence; David J Vocadlo; Biswa Choudhury; Jeffrey D Esko; Ajit Varki
Journal:  J Biol Chem       Date:  2012-06-12       Impact factor: 5.157

7.  Metabolism of vertebrate amino sugars with N-glycolyl groups: elucidating the intracellular fate of the non-human sialic acid N-glycolylneuraminic acid.

Authors:  Anne K Bergfeld; Oliver M T Pearce; Sandra L Diaz; Tho Pham; Ajit Varki
Journal:  J Biol Chem       Date:  2012-06-12       Impact factor: 5.157

8.  Chemoenzymatic Synthesis of 9NHAc-GD2 Antigen to Overcome the Hydrolytic Instability of O-Acetylated-GD2 for Anticancer Conjugate Vaccine Development.

Authors:  Xuanjun Wu; Jinfeng Ye; Andrew T DeLaitsch; Zahra Rashidijahanabad; Shuyao Lang; Tayeb Kakeshpour; Yuetao Zhao; Sherif Ramadan; Paulo Vilar Saavedra; Vilma Yuzbasiyan-Gurkan; Herbert Kavunja; Hongzhi Cao; Jeffrey C Gildersleeve; Xuefei Huang
Journal:  Angew Chem Int Ed Engl       Date:  2021-10-04       Impact factor: 15.336

9.  Rapid analysis of O-acetylated neuraminic acids by matrix assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  P Stehling; M Gohlke; R Fitzner; W Reutter
Journal:  Glycoconj J       Date:  1998-04       Impact factor: 2.916

Review 10.  Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy.

Authors:  Sophie Groux-Degroote; Philippe Delannoy
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.